The Role of Pollen Starch Granules in Pollen Challenge Studies in the Fraunhofer Environmental Exposure Unit
NCT00209365 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2017-02-15
Summary
The aim of the study is to explore the contribution of pollen starch granules to the induced symptoms and airway inflammation in patients with allergic rhinitis and mild asthma in a controlled pollen exposure(pollen challenge room at the Fraunhofer ITEM). Starch granules are released from the pollen grains and are considered to be the allergen carriers of the pollen. The hypothesis is proposed that pollen starch granules are important in the induction of airway inflammation and airway hyperresponsiveness.
Conditions
- Asthma
- Seasonal Allergic Rhinitis
Interventions
- PROCEDURE
-
exposure to grass pollen/starch granules
Sponsors & Collaborators
-
Fraunhofer-Institute of Toxicology and Experimental Medicine
lead OTHER
Principal Investigators
-
Norbert Krug, MD · Fraunhofer ITEM
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-09-30
- Completion
- 2005-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation
NCT00623701 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of Nutrition on Nasal and Bronchial Affliction in Patients With Allergy on Grass-Pollen
NCT00519740 ·Status: COMPLETED ·Phase: NA
-
Resolution of Allergic Inflammation
NCT01992835 ·Status: COMPLETED ·Phase: NA
-
Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber
NCT03496103 ·Status: COMPLETED ·Phase: PHASE1
-
Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma
NCT01634958 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens
NCT00666341 ·Status: COMPLETED ·Phase: PHASE2
-
Phleum Pratense and Dactylis Glomerata Allergen Extracts Standardization
NCT06957496 ·Status: COMPLETED ·Phase: NA
-
Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma
NCT00135642 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children
NCT00841256 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber
NCT02166268 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Perennial and Preseasonal Subcutaneous Immunotherapy
NCT01555736 ·Status: COMPLETED ·Phase: PHASE4
-
Allergic Inflammation in Rhinitis Patients Following Nasal Allergen Challenge
NCT01657097 ·Status: COMPLETED ·Phase: PHASE4
-
Open Label Safety Study of a Birch Pollen Allergen Extract
NCT00818181 ·Status: COMPLETED ·Phase: PHASE2
-
Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen
NCT00916422 ·Status: COMPLETED ·Phase: PHASE3
-
Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis
NCT05346718 ·Status: COMPLETED ·Phase: NA
-
Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels
NCT04389034 ·Status: COMPLETED
-
Effect of a Probiotic on Seasonal Allergic Rhinitis Symptoms
NCT01653652 ·Status: COMPLETED ·Phase: NA
-
Biological Standardization of Allergen Extracts of Pollens of Betula Pendula, Phleum Pratense and Mite Extract of Dermatophagoides Pteronyssinus
NCT01147159 ·Status: COMPLETED ·Phase: PHASE2
-
Determination of Grass Pollen Allergen Concentration Inducing Rhinoconjunctivitis Symptoms in Subjects Allergic to Grass Pollen in ALYATEC Allergen Exposure Chamber
NCT06104293 ·Status: COMPLETED ·Phase: NA
-
Biological Standardization of D. Glomerata, L. Perenne, S. Cereale and O. Europaea Pollen Extracts
NCT01567319 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)
NCT01385371 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Nasal and Conjunctival Response in Subjects Allergic to Birch Pollen in the ALYATEC Environmental Exposure Chamber
NCT04583202 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Safety, Tolerability and Explorative Efficacy of DM-101PX in Birch Pollen Allergic Participants
NCT06037148 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of FP-025, on Allergen-induced Airway Responses in Mild Eosinophilic House Dust Mite (HDM)-Allergic Asthma.
NCT03858686 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712)
NCT01469234 ·Status: COMPLETED ·Phase: PHASE4